Medicare Enrolled
Dr. David Aftergood, MD
Endocrinology · Beverly Hills, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Aftergood from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Aftergood?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Aftergood
Dr. David Aftergood is an endocrinology specialist in Beverly Hills, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Aftergood performed 3,873 Medicare services across 2,139 unique beneficiaries.
Between the years covered by Open Payments, Dr. Aftergood received a total of $28,674 from 82 pharmaceutical and/or device companies across 1455 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Aftergood is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 20% volume in CA
$28,674 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,873
Medicare services
Top 20% in CA for endocrinology
2,139
Unique beneficiaries
$65
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~204 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,525 | $107 | $435 |
| Venipuncture for blood draw Insertion of a needle into a vein to collect blood samples. This procedure is performed on patients aged 3 years or older. |
742 | $15 | $75 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
636 | $76 | $368 |
| Hemoglobin a1c level, by device for home use | 618 | $10 | $50 |
| Ultrasound of head and neck soft tissue This procedure uses sound waves to create images of the soft tissues in the head and neck area. It allows for the visualization of structures beneath the skin without using radiation. |
113 | $102 | $288 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
99 | $48 | $249 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
48 | $13 | $89 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
38 | $146 | $508 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
34 | $19 | $107 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
20 | $8 | $30 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$28,674
Total received (2018-2024)
Avg $4,096/year across 7 years
Top 11% in CA for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
82
Companies
1,455
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$28,674 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,853
2023
$4,584
2022
$4,635
2021
$4,274
2020
$2,785
2019
$3,989
2018
$3,555
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$673
Boehringer Ingelheim Pharmaceuticals, Inc.
$413
Corcept Therapeutics
$403
Novo Nordisk Inc
$383
Abbott Laboratories
$352
Radius Health, Inc.
$259
Mannkind Corporation
$253
Xeris Pharmaceuticals, Inc.
$246
ABBVIE INC.
$227
Amgen Inc.
$203
RECORDATI_RARE_DISEASES_INC.
$192
Dexcom, Inc.
$186
Insulet Corporation
$137
Tandem Diabetes Care, Inc.
$129
IBSA Pharma Inc.
$108
Novartis Pharmaceuticals Corporation
$106
CeQur Corporation
$67
Ascensia Diabetes Care Us Inc.
$62
Lexicon Pharmaceuticals, Inc.
$53
Alvogen Inc
$44
Astellas Pharma US Inc
$42
Medtronic, Inc.
$38
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$38
Regeneron Healthcare Solutions, Inc.
$36
Tolmar, Inc.
$35
Currax Pharmaceuticals LLC
$31
Acella Pharmaceuticals, LLC
$30
BETA BIONICS, INC.
$27
Alexion Pharmaceuticals, Inc.
$26
Antares Pharma, Inc.
$22
Intra-Sana Laboratories
$18
Bayer Healthcare Pharmaceuticals Inc.
$15
Top 3 companies account for 30.7% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$3,260
Lilly USA, LLC
$2,938
Boehringer Ingelheim Pharmaceuticals, Inc.
$2,072
Amgen Inc.
$1,381
Corcept Therapeutics
$1,294
Abbott Laboratories
$1,211
SANOFI-AVENTIS U.S. LLC
$1,207
Radius Health, Inc.
$1,121
AstraZeneca Pharmaceuticals LP
$1,101
AbbVie Inc.
$868
Insulet Corporation
$859
IBSA Pharma Inc.
$736
Janssen Pharmaceuticals, Inc
$659
Mannkind Corporation
$583
Merck Sharp & Dohme Corporation
$563
AbbVie, Inc.
$505
ABBVIE INC.
$469
RECORDATI_RARE_DISEASES_INC.
$411
Currax Pharmaceuticals LLC
$411
Tandem Diabetes Care, Inc.
$388
MannKind Corporation
$384
Bayer HealthCare Pharmaceuticals Inc.
$373
Xeris Pharmaceuticals, Inc.
$369
Dexcom, Inc.
$368
Horizon Therapeutics plc
$317
Novartis Pharmaceuticals Corporation
$296
Antares Pharma, Inc.
$272
Amarin Pharma Inc.
$257
Alexion Pharmaceuticals, Inc.
$257
VistaPharm, Inc.
$257
Becton, Dickinson and Company
$243
Medtronic, Inc.
$226
Shire North American Group Inc
$170
Endo Pharmaceuticals Inc.
$160
Embecta Corp.
$160
Bayer Healthcare Pharmaceuticals Inc.
$146
Eisai Inc.
$143
Alfasigma USA, Inc.
$134
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$121
CeQur Corporation
$111
Gemini Laboratories, LLC
$111
Medtronic MiniMed, Inc.
$102
LifeScan, Inc.
$100
Zealand Pharma US, Inc.
$91
EUSA Pharma (US) LLC
$84
Ascensia Diabetes Care Us Inc.
$82
Regeneron Healthcare Solutions, Inc.
$78
Lexicon Pharmaceuticals, Inc.
$74
Ipsen Biopharmaceuticals, Inc
$73
Alvogen Inc
$70
GRT US Holding, Inc.
$61
VIVUS, Inc.
$59
Allergan, Inc.
$57
Kyowa Kirin, Inc.
$56
Tolmar, Inc.
$49
ARBOR PHARMACEUTICALS, INC.
$49
Supernus Pharmaceuticals, Inc.
$48
Acerus Pharmaceuticals Corporation
$42
Astellas Pharma US Inc
$42
DEXCOM, INC.
$37
Kowa Pharmaceuticals America, Inc.
$36
Amneal Pharmaceuticals LLC
$36
Acella Pharmaceuticals, LLC
$30
BETA BIONICS, INC.
$27
Biohaven Pharmaceutical Holding Company Ltd.
$27
Senseonics, Incorporated
$27
Bigfoot Biomedical Inc
$26
Valeritas, Inc.
$26
LIFESCAN, INC.
$25
Exact Sciences Corporation
$24
VIVUS LLC
$23
Amryt Pharma Holdings Ltd
$23
Esperion Therapeutics, Inc.
$21
GENZYME CORPORATION
$20
Nalpropion Pharmaceuticals LLC
$19
Clarus Therapeutics Inc.
$19
PFIZER INC.
$18
Arbor Pharmaceuticals, Inc.
$18
Intra-Sana Laboratories
$18
EISAI INC.
$18
Optos, Inc.
$15
Medicure Pharma Inc.
$14
Top 3 companies account for 28.8% of all-time payments
Associated products mentioned in payments ›
ACCURIAN · AFREZZA · AUBAGIO · AVEED · Aimovig · Androgel · BAQSIMI · BASAGLAR · BD Nano · BD Nano 2nd Gen Pen Needle · BD Ultra-Fine · BELSOMRA · BYDUREON · Belviq · COLOGUARD · CONTRAVE · CeQur Simplicity · Cologuard Collection Kit · Corlanor · Creon · Crysvita · DEXCOM CGM · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · Dayvigo · Dexcom CGM · Dexcom G6 Transmitter · ENTRESTO · EVENITY · EVERSENSE E3 SENSOR KIT - RETAIL · EVKEEZA · Edarbi · Eversense · FARXIGA · FORTEO · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre blood glucose Flash Monitoring System · GLYCATE · GVOKE HYPOPEN · GVOKE PFS · HUMALOG · HUMULIN · INVOKANA · ISTURISA · Inpefa · JANUVIA · JARDIANCE · JATENZO · Kerendia · Korlym · LEQVIO · LICART · LINZESS · Licart · Livalo · MINIMED 770G · MOUNJARO · MYCAPSSA · Minimed 670G System · Minimed 770G System · NASCOBAL · NATPARA · NATPARA (PARATHYROID HORMONE) · NEXLETOL · NOCDURNA · NP Thyroid 60 · NURTEC ODT · Natesto · ONETOUCH VERIO REFLECT · OT Verio Reflect "One Touch Meter and Strips" · OTREXUP · Omnipod · OneTouch · OneTouch Verio Reflect · Otrexup · Ozempic · PANORAMIC OPHTHALMOSCOPE · PRALUENT · Prolia · QSYMIA · QULIPTA · Qutenza · RECORLEV · RETEVMO · RYBELSUS · Repatha · Rybelsus · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · SOMATULINE DEPOT · STEGLATRO · STRENSIQ · SYNTHROID · Saxenda · Strensiq · Sylvant · Synthroid · TEPEZZA · TERIPARATIDE · TLANDO · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Thyquidity · Tirosint · Tresiba · Tymlos · UBRELVY · UNITHROID · UNITY DIABETES MANAGEMENT SYSTEM · V-GO · V-GO DISPOSABLE INSULIN DELIVERY · Vascepa · Veozah · Victoza · Wegovy · XARELTO · XIFAXAN · XYOSTED · ZEGALOGUE · ZEPBOUND · ZYPITAMAG · iLet Bionic Pancreas · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Endocrinologists within 10 mi
271
Per 100K population
2.8
County median income
$87,760
Nearest hospital
CEDARS-SINAI MEDICAL CENTER
0.8 mi
0.8 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Aftergood is a clinical cardiology specialist, with above-average Medicare volume (top 20% in CA), with low-engagement industry engagement in the top 11% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Aftergood experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Aftergood performed 1,525 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Aftergood receive payments from pharmaceutical companies?
Yes. Dr. Aftergood received a total of $28,674 from 82 companies across 1,455 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Aftergood's costs compare to other endocrinologists in Beverly Hills?
Dr. Aftergood's average Medicare payment per service is $65. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Aftergood) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Endocrinology
Common procedures, typical costs, and what industry payments mean in endocrinology.
Same specialty & city
Endocrinologists in Beverly Hills
Browse endocrinologists in Beverly Hills ranked by procedure volume and transparency data.
Highest volume
Top Endocrinologists in CA
Endocrinologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Endocrinologists in CA
Which CA endocrinologists receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology